Markers of type 3 inflammation were even less commonly overexpressed among the myositis groups, with exceptions being IL22RA1 in DM and CCL20 in Jo1 (Figure 3, Supplemental Table 5). This evidence concerns the gene IL22RA1 and dermatomyositis.